{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T23:00:58Z","timestamp":1768777258107,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103673 and 82002877"],"award-info":[{"award-number":["82103673 and 82002877"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-024-04865-8","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T13:02:31Z","timestamp":1726491751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The first description of mucous membrane pemphigoid induced by enalapril maleate: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Yihang","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiongke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"4865_CR1","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/ced.13996","volume":"44","author":"B Carey","year":"2019","unstructured":"Carey B, Setterfield J. Mucous membrane pemphigoid and oral blistering diseases. Clin Exp Dermatol. 2019;44:732\u20139.","journal-title":"Clin Exp Dermatol"},{"key":"4865_CR2","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1111\/jdv.15679","volume":"33","author":"BS Daniel","year":"2019","unstructured":"Daniel BS, Murrell DF. Review of autoimmune blistering diseases: the pemphigoid diseases. J Eur Acad Dermatol Venereol. 2019;33:1685\u201394.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4865_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1684\/ejd.2021.4132","volume":"32","author":"MS Alrashdan","year":"2022","unstructured":"Alrashdan MS, Kamaguchi M. Management of mucous membrane pemphigoid: a literature review and update. Eur J Dermatol. 2022;32:312\u201321.","journal-title":"Eur J Dermatol"},{"key":"4865_CR4","doi-asserted-by":"publisher","first-page":"103036","DOI":"10.1016\/j.autrev.2022.103036","volume":"21","author":"G Du","year":"2022","unstructured":"Du G, Patzelt S, van Beek N, Schmidt E. Mucous membrane pemphigoid. Autoimmun Rev. 2022;21:103036.","journal-title":"Autoimmun Rev"},{"key":"4865_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.cden.2013.07.003","volume":"57","author":"HH Xu","year":"2013","unstructured":"Xu HH, Werth VP, Parisi E, Sollecito TP. Mucous membrane pemphigoid. Dent Clin North Am. 2013;57:611\u201330.","journal-title":"Dent Clin North Am"},{"key":"4865_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0738-081X(98)00008-X","volume":"16","author":"S Vassileva","year":"1998","unstructured":"Vassileva S. Drug-induced pemphigoid: bullous and cicatricial. Clin Dermatol. 1998;16:379\u201387.","journal-title":"Clin Dermatol"},{"key":"4865_CR7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/bjd.16780","volume":"179","author":"V Haug","year":"2018","unstructured":"Haug V, Behle V, Benoit S, Kneitz H, Schilling B, Goebeler M, et al. Pembrolizumab-associated mucous membrane pemphigoid in a patient with Merkel cell carcinoma. Br J Dermatol. 2018;179:993\u20134.","journal-title":"Br J Dermatol"},{"key":"4865_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ejca.2019.08.030","volume":"121","author":"V Sibaud","year":"2019","unstructured":"Sibaud V, Vigarios E, Siegfried A, Bost C, Meyer N, Pages-Laurent C. Nivolumab-related mucous membrane pemphigoid. Eur J Cancer. 2019;121:172\u20136.","journal-title":"Eur J Cancer"},{"key":"4865_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41415-024-7064-x","volume":"236","author":"R Kulkarni","year":"2024","unstructured":"Kulkarni R, E TS TPS. Oral mucous membrane pemphigoid: updates in diagnosis and management. Br Dent J. 2024;236:293\u20136.","journal-title":"Br Dent J"},{"key":"4865_CR10","first-page":"1530","volume":"20","author":"SC Hofmann","year":"2022","unstructured":"Hofmann SC, G\u00fcnther C, B\u00f6ckle BC, Didona D, Ehrchen J, Gaskins M, et al. S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid. J Dtsch Dermatol Ges. 2022;20:1530\u201350.","journal-title":"J Dtsch Dermatol Ges"},{"key":"4865_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fimmu.2019.00034","volume":"10","author":"M Kamaguchi","year":"2019","unstructured":"Kamaguchi M, Iwata H. The diagnosis and blistering mechanisms of mucous membrane Pemphigoid. Front Immunol. 2019;10:34.","journal-title":"Front Immunol"},{"key":"4865_CR12","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1111\/jdv.17395","volume":"35","author":"E Schmidt","year":"2021","unstructured":"Schmidt E, Rashid H, Marzano AV, Lamberts A, Di Zenzo G, Diercks GFH, et al. European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II. J Eur Acad Dermatol Venereol. 2021;35:1926\u201348.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4865_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.autrev.2019.02.005","volume":"18","author":"A Buonavoglia","year":"2019","unstructured":"Buonavoglia A, Leone P, Dammacco R, Di Lernia G, Petruzzi M, Bonamonte D, et al. Pemphigus and mucous membrane pemphigoid: an update from diagnosis to therapy. Autoimmun Rev. 2019;18:349\u201358.","journal-title":"Autoimmun Rev"},{"key":"4865_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/1752-1947-6-373","volume":"6","author":"P Kanjanabuch","year":"2012","unstructured":"Kanjanabuch P, Arporniem S, Thamrat S, Thumasombut P. Mucous membrane pemphigoid in a patient with hypertension treated with atenolol: a case report. J Med Case Rep. 2012;6:373.","journal-title":"J Med Case Rep"},{"issue":"Suppl 5","key":"4865_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2165\/00003495-198600325-00005","volume":"32","author":"F Fyhrquist","year":"1986","unstructured":"Fyhrquist F. Clinical pharmacology of the ACE inhibitors. Drugs. 1986;32(Suppl 5):33\u20139.","journal-title":"Drugs"},{"key":"4865_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2165\/00003088-200241030-00005","volume":"41","author":"JC Song","year":"2002","unstructured":"Song JC, White CM. Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update. Clin Pharmacokinet. 2002;41:207\u201324.","journal-title":"Clin Pharmacokinet"},{"key":"4865_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1365-2796.1995.tb00917.x","volume":"238","author":"T Forslund","year":"1995","unstructured":"Forslund T, Tohmo H, Weckstr\u00f6m G, Stenborg M, J\u00e4rvinen S. Angio-Oedema induced by enalapril. J Intern Med. 1995;238:179\u201381.","journal-title":"J Intern Med"},{"key":"4865_CR18","first-page":"1021","volume":"11","author":"P Pietkiewicz","year":"2015","unstructured":"Pietkiewicz P, Gornowicz-Porowska J, Bowszyc-Dmochowska M, Dmochowski M. A retrospective study of antihypertensives in pemphigus: a still unchartered odyssey particularly between thiols, amides and phenols. Arch Med Sci. 2015;11:1021\u20137.","journal-title":"Arch Med Sci"},{"key":"4865_CR19","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/0190-9622(93)70262-R","volume":"29","author":"EP Smith","year":"1993","unstructured":"Smith EP, Taylor TB, Meyer LJ, Zone JJ. Antigen identification in drug-induced bullous pemphigoid. J Am Acad Dermatol. 1993;29:879\u201382.","journal-title":"J Am Acad Dermatol"},{"key":"4865_CR20","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1590\/S0365-05962011000600023","volume":"86","author":"AR Adriano","year":"2011","unstructured":"Adriano AR, Gomes Neto A, Hamester GR, Nunes DH, Di Giunta G. Pemphigus vegetans induced by use of enalapril. Bras Dermatol. 2011;86:1197\u2013200.","journal-title":"Bras Dermatol"},{"key":"4865_CR21","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.autrev.2017.03.010","volume":"16","author":"IS Ba\u011fc\u0131","year":"2017","unstructured":"Ba\u011fc\u0131 IS, Horv\u00e1th ON, Ruzicka T, S\u00e1rdy M. Bullous pemphigoid. Autoimmun Rev. 2017;16:445\u201355.","journal-title":"Autoimmun Rev"},{"key":"4865_CR22","first-page":"e57054","volume":"16","author":"K Bisht","year":"2024","unstructured":"Bisht K, Khuraijam S, Theresa Sony H, Kumbhar S. An Urticarial and Acral Manifestation of Bullous Pemphigoid after Vildagliptin Therapy: a Case Report. Cureus. 2024;16:e57054.","journal-title":"Cureus"},{"key":"4865_CR23","first-page":"9676","volume":"15","author":"B Sonego","year":"2023","unstructured":"Sonego B, Zelin E, Zalaudek I, di Meo N. Bullous pemphigoid triggered by dulaglutide: a case report and a review of the literature. Dermatol Rep. 2023;15:9676.","journal-title":"Dermatol Rep"},{"key":"4865_CR24","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1002\/ski2.176","volume":"2","author":"SM Dyson","year":"2022","unstructured":"Dyson SM, Patel PU, Igali L, Millington GWM. Bullous pemphigoid in a patient with a neuropsychological disorder and a possible novel drug trigger: a case report and review of the literature. Skin Health Dis. 2022;2:e176.","journal-title":"Skin Health Dis"},{"key":"4865_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1203475420972349","volume":"25","author":"M Armanious","year":"2021","unstructured":"Armanious M, AbuHilal M. Gliptin-Induced Bullous Pemphigoid: Canadian Case Series of 10 patients. J Cutan Med Surg. 2021;25:163\u20138.","journal-title":"J Cutan Med Surg"},{"key":"4865_CR26","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.cjco.2021.06.003","volume":"3","author":"JC Liang","year":"2021","unstructured":"Liang JC, Raman K, Chan SH, Tashakkor AY. Rivaroxaban-Associated Bullous Pemphigoid in a patient with Atrial Fibrillation. CJC Open. 2021;3:1316\u20139.","journal-title":"CJC Open"},{"key":"4865_CR27","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/jdv.12366","volume":"28","author":"PG Stavropoulos","year":"2014","unstructured":"Stavropoulos PG, Soura E, Antoniou C. Drug-induced pemphigoid: a review of the literature. J Eur Acad Dermatol Venereol. 2014;28:1133\u201340.","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-024-04865-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-024-04865-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-024-04865-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T13:04:44Z","timestamp":1726491884000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-024-04865-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4865"],"URL":"https:\/\/doi.org\/10.1186\/s12903-024-04865-8","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"17 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of West China Hospital of Stomatology, Sichuan University, approved this study. The patient in this manuscript provided written informed consent for participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient in this manuscript provided written informed consent for publishing this case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1096"}}